Impact of Postdilation on Intervention Success and Long-Term Major Adverse Cardiovascular Events (MACE) among Patients with Acute Coronary Syndromes

Impact of Postdilation on Intervention Success and Long-Term Major Adverse Cardiovascular Events (MACE) among Patients with Acute Coronary Syndromes

Postdilation is frequently used during coronary interventions to prevent stent malapposition. Currently there are contradictory findings regarding the benefits of postdilation for both intraprocedural and long-term outcomes. We evaluated the impact of postdilation among patients who presented with a...

Full description

Bibliographic Details
Main Authors:	Turan Erdoğan, Hakan Duman, Mustafa Çetin, Savaş Özer, Göksel Çinier, Ece Usta, Mustafa Usta, Tuncay Kırış
Format:	Article
Language:	English
Published:	Compuscript Ltd 2020-01-01
Series:	Cardiovascular Innovations and Applications
Online Access:	https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2019.0564

Similar Items

Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients
by: Mustafa Çetin, et al.
Published: (2020-04-01)

Prolonged QRS independently predicts long-term all-cause mortality in patients with narrow QRS complex undergoing coronary artery bypass grafting surgery (9-year follow-up results)
by: Turan Erdoğan, et al.
Published: (2020-09-01)

Left ventricular hypertrophy is associated with increased sirtuin level in newly diagnosed hypertensive patients
by: Hakan Duman, et al.
Published: (2019-08-01)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
by: Hossein Farshidi, et al.
Published: (2018-02-01)

Anatomic Distribution of Coronary Culprit Lesion and Five-Year Follow-Up for Major Adverse Cardiac Events (MACE) in Patients with Acute Coronary Syndrome
by: Seyed Mohammad Hashemi, et al.
Published: (2017-10-01)

Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
by: Gaoqiang Xie, et al.
Published: (2017-08-01)

Original paper<br>C-reactive protein as a predictor of major adverse cardiac events (MACE) after percutaneous coronary intervention?
by: Leszek Markuszewski, et al.
Published: (2005-11-01)

1239 Major adverse cardiovascular events (MACE) in patients with melanoma receiving immune checkpoint inhibitors
by: Bo Zhao, et al.
Published: (2023-11-01)

The Relationship of Apolipoprotein B and Major Adverse Cardiovascular Events (MACE) in Patients with Coronary Heart Disease as a Prognostic Factor: A Literature Review
by: Andrea Radyaputri
Published: (2024-02-01)

Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate
by: Li Na, et al.
Published: (2023-05-01)

The Relationship Between Mean Platelet Volume and In-Hospital Mortality in Geriatric Patients with ST Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention
by: Ömer Şatıroğlu, et al.
Published: (2019-06-01)

K-MACE and Kernel K-MACE Clustering
by: Soosan Beheshti, et al.
Published: (2020-01-01)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
by: Dongqing Chen, et al.
Published: (2023-04-01)

Retrospective Study of Appropriate Primary Prevention in Postmenopausal Women Presenting with a Major Adverse Cardiovascular Endpoint (MACE)
by: Nicole E. Cieri-Hutcherson, et al.
Published: (2022-08-01)

Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
by: Josep Ramon Marsal, et al.
Published: (2022-12-01)

A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
by: Dong Huang, et al.
Published: (2022-09-01)

Is Premature Hair Whitening a Predictor of Hypertension for Healthy Young and Middle-Aged Men?
by: Turan Erdoğan, et al.
Published: (2020-06-01)

71 Percutaneous Coronary Intervention (PCI) Risk Scores Predicting Inpatient Mortality and Major Adverse Cardiac Events (MACE) are Poorly Concordant in High Risk Patients.
by: Ruparelia, N, et al.
Published: (2014)

Left Main Coronary Artery Bifurcation Lesions: Two Stents vs One Stent Strategy-Comparison of Major Adverse Cardiac Events (MACE) at 2 years
by: Hafiz Muhammad Shafique, et al.
Published: (2022-11-01)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
by: Kallis C, et al.
Published: (2023-11-01)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
by: Celestino Sardu, et al.
Published: (2019-09-01)

Designing for Student Well-Being
by: Usta, Nazlı Ece
Published: (2022)

Time‐Integrated Aortic Regurgitation Index Helps Guide Balloon Postdilation During Transcatheter Aortic Valve Replacement and Predicts Survival
by: Arnav Kumar, et al.
Published: (2019-07-01)

Warta MACEE
by: Malaysian-American Commission in Educational Exchange
Published: (1958)

Epicardial adipose tissue predicted prolonged QTc interval in patients with arterial hypertension
by: Ahmet Seyda Yılmaz, et al.
Published: (2021-04-01)

Predictors for the prolonged R wave peak time among patients with arterial hypertension
by: Göksel Çinier, et al.
Published: (2021-07-01)

LP-064 Effect of osteoporosis on major adverse cardiovascular events (MACEs) in systemic lupus erythematosus (SLE): a longitudinal study
by: Ling Yin Ho, et al.
Published: (2023-07-01)

Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
by: Sinem Çakal, et al.
Published: (2021-01-01)

Prevalence of major adversecardiovascular events (MACEs) post angioplasty-HUSM Experience
by: Ng Seng, Loong
Published: (2008)

Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome
by: Huilong Duan, et al.
Published: (2019-01-01)

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
by: Luis A. Rosario Arroyo, et al.
Published: (2022-04-01)

Rhinitis induced to mace
by: Sanchez Moreno Gema, et al.
Published: (2011-08-01)

Detection and Molecular Characterization of ‘Candidatus Phytoplasma Trifolii’, a Member of the Clover Proliferation Grup, Infecting Tomato Plants from Iğdır Province in Turkey
by: Mustafa Usta, et al.
Published: (2020-12-01)

THE EFFECTS OF BORON COMPOUNDS AND DIFFERENT MELAMINE CONTENTS IN MUF RESINS ON SOME PROPERTIES OF MDF PANELS
by: Derya Ustaomer,, et al.
Published: (2011-11-01)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
by: Andryanto Sutanto, et al.
Published: (2021-10-01)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
by: Hector Jose Nunez Medina, et al.
Published: (2020-06-01)

Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality
by: Christos Eftychiou, et al.
Published: (2021-01-01)

Evidential MACE prediction of acute coronary syndrome using electronic health records
by: Danqing Hu, et al.
Published: (2019-04-01)

Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome
by: Hakan Duman MD, et al.
Published: (2019-01-01)

Performance of HEART and TIMI scores in predicting major adverse cardiovascular events (MACEs) of chest pain patients in the emergency department: A prospective observational study
by: Sonal Kaushal Ginoya, et al.
Published: (2021-01-01)